Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.61 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.61 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.61 |
| ▸ | KDM6B | O15054 | 1/20 | 0.61 |
| ▸ | KDM5C | P41229 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 6/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.34 |
| ▸ | PPARG | P37231 | 6/20 | 0.34 |
| ▸ | PPARD | Q03181 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28780950 | 0.85 | GPR84 (0.50) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL11344696 | 0.85 | GPR84 (0.50) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL10627980 | 0.84 | GPR84 (0.48) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL28789565 | 0.82 | TSHR (0.59) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL28949052 | 0.81 | DGKA (0.41) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL17686889 | 0.81 | ALDH1A1 (0.52) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL5926969 | 0.79 | KDM6B (0.37) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL4399606 | 0.79 | DGKA (0.45) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| SCHEMBL28054434 | 0.78 | KDM6B (0.38) | PHF8KDM2AEGLN1KDM6BKDM5C | |
| Hydrochloric Acid SCHEMBL5514211 | 0.77 | KDM6B (0.35) | PHF8KDM2AEGLN1KDM6BKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006046114-A2 | OSMOTIC DOSAGE FORMS PROVIDING ASCENDING DRUG RELEASE, AND PROCESSES FOR THEIR PREPARATION | RANBAXY LABORATORIES LIMITED (IN) | 2006-05-04 | — | — | WO | claimed |
| EP-1622591-A1 | BIPHASIC RELEASE OF GLIPIZIDE FROM MONOCOMPARTMENT OSMOTIC DOSAGE FORM | RANBAXY LABORATORIES, LTD. (IN) | 2006-02-08 | — | — | EP | claimed |
| US-20050208135-A1 | Monocompartment osmotic controlled drug delivery system | RANBAXY LABORATORIES LIMITED (IN) | 2005-09-22 | — | — | US | claimed |
| EP-1503740-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | Ranbaxy Laboratories Limited (IN) | 2005-02-09 | — | — | EP | claimed |
| WO-2004098572-A1 | BIPHASIC RELEASE OF GLIPIZIDE FROM MONOCOMPARTMENT OSMOTIC DOSAGE FORM | RANBAXY LABORATORIES LIMITED (US) | 2004-11-18 | — | — | WO | claimed |
| WO-2003092660-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | RANBAXY LABORATORIES LIMITED (US) | 2003-11-13 | — | — | WO | claimed |
| US-10137094-B2 | Gastroretentive dosage system and process of preparation thereof | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2018-11-27 | — | — | US | disclosed |
| CN-106074417-A | The pharmaceutical carrier of slow-release | 钟术光 | 2016-11-09 | — | — | CN | disclosed |
| US-20140271846-A1 | GASTRORETENTIVE DOSAGE SYSTEM AND PROCESS OF PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2014-09-18 | — | — | US | disclosed |
| EP-2765998-A1 | A GASTRORETENTIVE DOSAGE SYSTEM AND PROCESS OF PREPARATION THEREOF | Ranbaxy Laboratories Limited (IN) | 2014-08-20 | — | — | EP | disclosed |
| WO-2013054285-A1 | A GASTRORETENTIVE DOSAGE SYSTEM AND PROCESS OF PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2013-04-18 | — | — | WO | disclosed |
| EP-1824491-A1 | MONOCOMPARTMENT OSMOTIC-CONTROLLED DELIVERY SYSTEM OF DOXAZOSIN | Ranbaxy Laboratories Limited (IN) | 2007-08-29 | — | — | EP | disclosed |
| US-20060233875-A1 | Taste masked sumatriptan tablets and processes for their preparation | RANBAXY LABORATORIES LIMITED (IN) | 2006-10-19 | — | — | US | disclosed |
| EP-1524978-A2 | TASTE MASKED SUMATRIPTAN TABLETS AND PROCESSES FOR THEIR PREPARATION | RANBAXY LABORATORIES, LTD. (IN) | 2005-04-27 | — | — | EP | disclosed |
| EP-1503740-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | Ranbaxy Laboratories Limited (IN) | 2005-02-09 | — | — | EP | disclosed |
| WO-2004098572-A1 | BIPHASIC RELEASE OF GLIPIZIDE FROM MONOCOMPARTMENT OSMOTIC DOSAGE FORM | RANBAXY LABORATORIES LIMITED (US) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004009085-A2 | TASTE MASKED SUMATRIPTAN TABLETS AND PROCESSES FOR THEIR PREPARATION | RANBAXY LABORATORIES LIMITED (IN) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003092660-A1 | MONOCOMPARTMENT OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM | RANBAXY LABORATORIES LIMITED (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2001091716-A1 | PERORAL THERAPEUTIC SYSTEM COMPRISING GLIPIZIDE | ADD ADVANCED DRUG DELIVERY TECHNOLOGIES AG (CH) | 2001-12-06 | — | — | WO | disclosed |
| US-4992278-A | Cellulose casing, core containing hydrophilic polymeric swelling agent blend of vinyl acetate-vinylpyrrolidone copolymer asnd polyoxyethylene glycol | CIBA-GEIGY CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |